Ankylosing Spondylitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of inflammatory arthritis called spondyloarthropathy, based on a recognised set of international classification standards
- People who are about to start a type of medication known as a TNF-inhibitor (a biologic drug that reduces inflammation)
Who may not be able to join:
- People who are unable to understand what the trial involves
- People who have a history of alcohol misuse
- People who have ever had a condition called diverticulitis (an infection or inflammation of small pouches in the bowel)
- People who have a history of not taking prescribed medications as directed
- People who are currently receiving any biologic therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kristofer Andréasson, MD PhD, Lund University Hospital
Phone: +4646172153
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in gut flora; Change in disease activity/treatment response at follow up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.